BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19712674)

  • 1. Immunogenicity and growth inhibitory efficacy of the prime-boost immunization regime with DNA followed by recombinant vaccinia virus carrying the P29 gene of Babesia gibsoni in dogs.
    Fukumoto S; Tamaki Y; Igarashi I; Suzuki H; Xuan X
    Exp Parasitol; 2009 Dec; 123(4):296-301. PubMed ID: 19712674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prime-boost immunization with DNA followed by a recombinant vaccinia virus expressing P50 induced protective immunity against Babesia gibsoni infection in dogs.
    Fukumoto S; Tamaki Y; Okamura M; Bannai H; Yokoyama N; Suzuki T; Igarashi I; Suzuki H; Xuan X
    Vaccine; 2007 Jan; 25(7):1334-41. PubMed ID: 17055131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prime-boost vaccination with plasmid DNA followed by recombinant vaccinia virus expressing BgGARP induced a partial protective immunity to inhibit Babesia gibsoni proliferation in dogs.
    Cao S; Mousa AA; Aboge GO; Kamyingkird K; Zhou M; Moumouni PF; Terkawi MA; Masatani T; Nishikawa Y; Suzuki H; Fukumoto S; Xuan X
    Acta Parasitol; 2013 Dec; 58(4):619-23. PubMed ID: 24338330
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heterologous prime-boost vaccination with a non-replicative vaccinia recombinant vector expressing LACK confers protection against canine visceral leishmaniasis with a predominant Th1-specific immune response.
    Ramos I; Alonso A; Marcen JM; Peris A; Castillo JA; Colmenares M; Larraga V
    Vaccine; 2008 Jan; 26(3):333-44. PubMed ID: 18093705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Babesia gibsoni ribosomal phosphoprotein P0 induces cross-protective immunity against B. microti infection in mice.
    Terkawi MA; Jia H; Zhou J; Lee EG; Igarashi I; Fujisaki K; Nishikawa Y; Xuan X
    Vaccine; 2007 Mar; 25(11):2027-35. PubMed ID: 17229504
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A heterologous prime-boost vaccination regime using DNA and a vaccinia virus, both expressing GRA4, induced protective immunity against Toxoplasma gondii infection in mice.
    Zhang G; Huong VT; Battur B; Zhou J; Zhang H; Liao M; Kawase O; Lee EG; Dautu G; Igarashi M; Nishikawa Y; Xuan X
    Parasitology; 2007 Sep; 134(Pt 10):1339-46. PubMed ID: 17506929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C3 contributes to the cross-protective immunity induced by Babesia gibsoni phosphoriboprotein P0 against a lethal B. rodhaini infection.
    Terkawi MA; Zhang G; Jia H; Aboge G; Goo YK; Nishikawa Y; Yokoyama N; Igarashi I; Kawazu SI; Fujisaki K; Xuan X
    Parasite Immunol; 2008; 30(6-7):365-70. PubMed ID: 18533933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccine strategies against Babesia bovis based on prime-boost immunizations in mice with modified vaccinia Ankara vector and recombinant proteins.
    Jaramillo Ortiz JM; Del Médico Zajac MP; Zanetti FA; Molinari MP; Gravisaco MJ; Calamante G; Wilkowsky SE
    Vaccine; 2014 Aug; 32(36):4625-32. PubMed ID: 24968152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prime-boost immunization with DNA and modified vaccinia virus ankara vectors expressing herpes simplex virus-2 glycoprotein D elicits greater specific antibody and cytokine responses than DNA vaccine alone.
    Meseda CA; Elkins KL; Merchlinsky MJ; Weir JP
    J Infect Dis; 2002 Oct; 186(8):1065-73. PubMed ID: 12355355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A 38-kDa protein from Babesia gibsoni and its antibody response in an experimentally infected dog.
    Zhou J; Zhang G; Nishikawa Y; Fujisaki K; Xuan X
    Vet Parasitol; 2006 Nov; 141(3-4):345-8. PubMed ID: 16815635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Babesia gibsoni: Serodiagnosis of infection in dogs by an enzyme-linked immunosorbent assay with recombinant BgTRAP.
    Goo YK; Jia H; Aboge GO; Terkawi MA; Kuriki K; Nakamura C; Kumagai A; Zhou J; Lee EG; Nishikawa Y; Igarashi I; Fujisaki K; Xuan X
    Exp Parasitol; 2008 Apr; 118(4):555-60. PubMed ID: 18155197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and expression of a 50-kilodalton surface antigen of Babesia gibsoni and evaluation of its diagnostic potential in an enzyme-linked immunosorbent assay.
    Fukumoto S; Xuan X; Nishikawa Y; Inoue N; Igarashi I; Nagasawa H; Fujisaki K; Mikami T
    J Clin Microbiol; 2001 Jul; 39(7):2603-9. PubMed ID: 11427577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Babesia gibsoni: identification, expression, localization, and serological characterization of a Babesia gibsoni 22-kDa protein.
    Goo YK; Jia H; Terkawi MA; Aboge GO; Yamagishi J; Nishikawa Y; Kim S; Jang HK; Fujisaki K; Xuan X
    Exp Parasitol; 2009 Nov; 123(3):273-6. PubMed ID: 19665019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serodiagnosis of canine Babesia gibsoni infection by enzyme-linked immunosorbent assay with recombinant P50 expressed in Escherichia coli.
    Fukumoto S; Sekine Y; Xuan X; Igarashi I; Sugimoto C; Nagasawa H; Fujisaki K; Mikami T; Suzuki H
    J Parasitol; 2004 Apr; 90(2):387-91. PubMed ID: 15165064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Babesia gibsoni: An apical membrane antigen-1 homologue and its antibody response in the infected dogs.
    Zhou J; Yang J; Zhang G; Nishikawa Y; Fujisaki K; Xuan X
    Exp Parasitol; 2006 Dec; 114(4):329-33. PubMed ID: 16777097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of a gene encoding a 29-kDa cytoplasmic protein of Babesia gibsoni and evaluation of its diagnostic potentiality.
    Fukumoto S; Xuan X; Inoue N; Igarashi I; Sugimoto C; Fujisaki K; Nagasawa H; Mikami T; Suzuki H
    Mol Biochem Parasitol; 2003 Oct; 131(2):129-36. PubMed ID: 14511811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective vaccination against experimental canine visceral leishmaniasis using a combination of DNA and protein immunization with cysteine proteinases type I and II of L. infantum.
    Rafati S; Nakhaee A; Taheri T; Taslimi Y; Darabi H; Eravani D; Sanos S; Kaye P; Taghikhani M; Jamshidi S; Rad MA
    Vaccine; 2005 May; 23(28):3716-25. PubMed ID: 15882533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of the protective effect of a prime-boost strategy with plasmid DNA followed by recombinant adenovirus expressing BmAMA1 as vaccines against Babesia microti infection in hamster.
    Wang G; Yu L; Efstratiou A; Moumouni PFA; Liu M; Guo H; Gao Y; Cao S; Zhou M; Li J; Ringo AE; Xuan X
    Acta Parasitol; 2018 Jun; 63(2):368-374. PubMed ID: 29654677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a practical immunochromatographic test with recombinant P50 for the diagnosis of Babesia gibsoni infection in dogs.
    Verdida RA; Xuan X; Fukumoto S; Huang X; Zhou J; Igarashi I; Claveria FG; Nagasawa H
    Parasitology; 2005 Dec; 131(Pt 6):769-74. PubMed ID: 16336730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of truncated Babesia gibsoni thrombospondin-related adhesive proteins in Escherichia coli and evaluation of their diagnostic potential by enzyme-linked immunosorbent assay.
    Narantsatsral S; Goo YK; Battsetseg B; Myagmarsuren P; Terkawi MA; Soma T; Luo Y; Li Y; Cao S; Yu L; Kamyingkird K; Aboge GO; Nishikawa Y; Xuan X
    Exp Parasitol; 2011 Oct; 129(2):196-202. PubMed ID: 21802417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.